| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 140, 1315-1325, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
SJ Hamilton-Dutoit and G Pallesen
Laboratory of immunohistology, Aarhus University Hospital, Denmark.
This study analyzes the association of Epstein-Barr virus (EBV) with non-Hodgkin's lymphoma (NHL) arising in patients without pre-existing overt immunodeficiency. The authors examined 201 lymphomas (105 high- grade B-cell, 82 peripheral T-cell, 7 high-grade non-B-cell, non-T- cell, and 7 hairy-cell leukemia) for EBV gene expression by immunohistologic procedures using monoclonal antibodies to EBV latent, immediate early, and replicative infection antigens. Transformation- associated EBV latent membrane protein 1 (LMP 1) was detected in 13 (6%) NHL, comprising 4 (4%) high-grade B-cell, 8 (10%) peripheral T- cell, and 1 non-B-cell, non-T-cell lymphomas. Anaplastic large-cell lymphoma of T-cell type was consistently LMP 1-negative. EBV nuclear antigen 2 was demonstrated in only three (1%) cases. Induction of replication as defined by expression of the immediate early BamHI Z leftward reading frame 1 (BZLF1) protein was detected in five cases, but early (EA) and late (VCA and MA) lytic cycle antigens were only found in two cases and in one case, respectively. The presence of EBV was confirmed by in situ DNA hybridization in 9 of 11 EBV antigen- positive lymphomas. This study shows the surprisingly frequent presence of EBV in peripheral T-cell NHL in European patients without pre- existing overt immunodeficiency. Interestingly, most sporadic B-cell NHL are not associated with the virus. Furthermore, the usefulness of selected monoclonal antibodies for the routine immunohistological diagnosis of EBV infection was confirmed.
This article has been cited by other articles:
![]() |
F. Boccellato, E. Anastasiadou, P. Rosato, B. Kempkes, L. Frati, A. Faggioni, and P. Trivedi EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells J. Virol., March 1, 2007; 81(5): 2274 - 2282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dupuis, J.-F. Emile, N. Mounier, C. Gisselbrecht, N. Martin-Garcia, T. Petrella, R. Bouabdallah, F. Berger, A. Delmer, B. Coiffier, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study Blood, December 15, 2006; 108(13): 4163 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Ingham, J. Raaijmakers, C. S. H. Lim, G. Mbamalu, G. Gish, F. Chen, L. Matskova, I. Ernberg, G. Winberg, and T. Pawson The Epstein-Barr Virus Protein, Latent Membrane Protein 2A, Co-opts Tyrosine Kinases Used by the T Cell Receptor J. Biol. Chem., October 7, 2005; 280(40): 34133 - 34142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Thompson and R. Kurzrock Epstein-Barr Virus and Cancer Clin. Cancer Res., February 1, 2004; 10(3): 803 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C.M. Straathof, C. M. Bollard, C. M. Rooney, and H. E. Heslop Immunotherapy for Epstein-Barr Virus-Associated Cancers in Children Oncologist, February 1, 2003; 8(1): 83 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quintanilla-Martinez, S. Kumar, F. Fend, E. Reyes, J. Teruya-Feldstein, D. W. Kingma, L. Sorbara, M. Raffeld, S. E. Straus, and E. S. Jaffe Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome Blood, July 15, 2000; 96(2): 443 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Chang, Y.-Y. Chen, W.-G. Chen, K. Hayashi, C. Bacchi, M. Bacchi, and L. M. Weiss EBNA-1 Gene Sequences in Brazilian and American Patients With Hodgkin's Disease Blood, July 1, 1999; 94(1): 244 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quintanilla-Martinez, C. Lome-Maldonado, G. Ott, A. Gschwendtner, E. Gredler, E. Reyes, A. Angeles-Angeles, and F. Fend Primary Non-Hodgkin's Lymphoma of the Intestine: High Prevalence of Epstein-Barr Virus in Mexican Lymphomas as Compared With European Cases Blood, January 15, 1997; 89(2): 644 - 651. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |